GK 664SAlternative Names: GK664S
Latest Information Update: 15 Jun 2016
At a glance
- Originator Maruho
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Plaque psoriasis
Most Recent Events
- 01 May 2016 Maruho completes a phase III trial in Plaque psoriasis in Japan (JapicCTI152858)
- 01 Jan 2015 Phase-III clinical trials in Plaque psoriasis in Japan (Topical) (JapicCTI152858)